Resveratrol
antioxidantAlso known as: trans-Resveratrol, 3,5,4'-Trihydroxystilbene, Red Wine Polyphenol
About
Resveratrol is a polyphenolic stilbene that activates SIRT1 and AMPK pathways, enhances endothelial nitric oxide production, and inhibits LDL oxidation. A 2015 meta-analysis of 10 RCTs found resveratrol at >=150 mg/day reduced systolic blood pressure by 11.9 mmHg in hypertensive patients. Bioavailability remains a challenge due to rapid hepatic metabolism.
How It Works
Activates SIRT1 and AMPK pathways enhancing mitochondrial biogenesis; potent inhibitor of LDL oxidation and foam cell formation; enhances endothelial nitric oxide synthase (eNOS) expression improving vasodilation; inhibits platelet aggregation through COX-1 and thromboxane A2 pathways; anti-inflammatory via NF-kB suppression.
Evidence For Conditions
| Condition | Grade | Studies | Participants | |
|---|---|---|---|---|
| High Blood Pressure (Hypertension) | B | 10 | 600 | View → |
| Atherosclerosis | C | 5 | 400 | View → |
Side Effects
- Gastrointestinal discomfort (nausea, diarrhea, cramping) at high doses
- Headache
- May have estrogenic activity at high doses
Drug & Supplement Interactions
- Anticoagulants (may inhibit platelet aggregation)
- CYP450 substrates (may inhibit CYP1A2, CYP3A4, CYP2D6)
- Blood pressure medications (additive hypotensive effect)
- Estrogen-sensitive conditions (weak estrogenic activity)
Always inform your healthcare provider about all supplements you take.
Related Ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.